Literature DB >> 30662799

miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D.

Lin Chen1, Huabin Gao1, Jiangtao Liang1, Junjing Qiao1, Jing Duan1, Huijuan Shi1, Tiantian Zhen1, Hui Li1, Fenfen Zhang1, Zhenwei Zhu2, Anjia Han1.   

Abstract

Colorectal cancer (CRC) is a major worldwide health problem due to its high prevalence and mortality rate. microRNA has been reported playing an important role in a variety of cancers including colorectal cancer. miR-203a-3p has been found up-regulated in CRC tissues compare with the adjacent normal tissues. But, how miR-203a-3p regulates CRC development remains to be elucidated. In this study, gain and loss-of-function assays showed that miR-203a-3p promotes colorectal cancer cell proliferation, colony formation and migration and invasion by targeting PDE4D. And miR-203a-3p/β-catenin/Cyclin D1/c-Myc signaling pathway is involved in the CRC. In summary, this study highlights an onco-miRNA role for miR-203a-3p by regulating PDE4D in CRC and suggests that miR-203a-3p may be a novel molecular therapeutic target for CRC.

Entities:  

Keywords:  Colorectal cancer; PDE4D; miR-203a-3p; micro-RNA

Year:  2018        PMID: 30662799      PMCID: PMC6325478     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  29 in total

1.  Noncoding RNAs in inflammation and colorectal cancer.

Authors:  Shengyun Ma; Tianyun Long; Wendy Jia Men Huang
Journal:  RNA Biol       Date:  2019-12-26       Impact factor: 4.652

2.  MiR-876-3p targets KIF20A to block JAK2/STAT3 pathway in glioma.

Authors:  Jiao Tang; Jie Xu; Zhongwen Zhi; Xiang Wang; Yu Wang; Yong Zhou; Rui Chen
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

3.  Construction and analysis of miRNA-mRNA regulatory networks in the radioresistance of nasopharyngeal carcinoma.

Authors:  Houyu Zhao; Aoshuang Chang; Junjun Ling; Wei Zhou; Huiping Ye; Xianlu Zhuo
Journal:  3 Biotech       Date:  2020-11-07       Impact factor: 2.406

4.  miR-203a-3p-DNMT3B feedback loop facilitates non-small cell lung cancer progression.

Authors:  Pingshan Yang; Dongdong Zhang; Fengli Zhou; Wenyou Chen; Chuang Hu; Duqing Xiao; Songwang Cai
Journal:  Hum Cell       Date:  2022-06-07       Impact factor: 4.174

5.  ZL-n-91, a specific Phosphodiesterase-4 inhibitor, suppresses the growth of triple-negative breast cancer.

Authors:  Longming Liang; Hansi Chen; Ping Mao; Yuyu Li; Lijun Xu; Yujie He; Yunping Mu; Allan Z Zhao; Sujin Zhou; Zhenggang Zhao; Fanghong Li
Journal:  Invest New Drugs       Date:  2022-06-08       Impact factor: 3.651

6.  Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches.

Authors:  Noor Ahmad Shaik; Khalidah Nasser; Arif Mohammed; Abdulrahman Mujalli; Ahmad A Obaid; Ashraf A El-Harouni; Ramu Elango; Babajan Banaganapalli
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 7.  PDE4 subtypes in cancer.

Authors:  Samuel Hsien Lai; Guston Zervoudakis; Jesse Chou; Mark E Gurney; Kelly M Quesnelle
Journal:  Oncogene       Date:  2020-03-20       Impact factor: 9.867

8.  Knockdown of miR-203a-3p alleviates the development of bronchopulmonary dysplasia partly via the up-regulation of vascular endothelial growth factor A.

Authors:  Hanrong Cheng; Li Chen; Yongli Wei; Tianyong Hu; Dongcai Li; Benqing Wu
Journal:  J Bioenerg Biomembr       Date:  2021-01-07       Impact factor: 2.945

Review 9.  A time to heal: microRNA and circadian dynamics in cutaneous wound repair.

Authors:  Sandra Fawcett; Raida Al Kassas; Iain M Dykes; Alun Tl Hughes; Fawaz Ghali; Kehinde Ross
Journal:  Clin Sci (Lond)       Date:  2022-04-29       Impact factor: 6.876

10.  The mechanisms of colorectal cancer cell mesenchymal-epithelial transition induced by hepatocyte exosome-derived miR-203a-3p.

Authors:  Heyang Xu; Qiusheng Lan; Yongliang Huang; Yang Zhang; Yujie Zeng; Pengwei Su; Ziqiang Chu; Wei Lai; Zhonghua Chu
Journal:  BMC Cancer       Date:  2021-06-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.